Definitive radiotherapy for nasopharyngeal carcinoma in Japan: analysis of cases in the National Head and Neck Cancer Registry from 2011 to 2014
Yutaro Koide(Aichi Cancer Center), Ken‐ichi Nibu(Japan Cancer Society), Takeshi Kodaira(Aichi Cancer Center), Megumi Kitayama(Wakayama Medical University), Munenaga Nakamizo(Tokyo Women's Medical University), Tadaaki Kirita(Nara Medical University), Daisuke Kawakita(Nagoya City University), Seiichi Yoshimoto(Tokyo National Hospital)
Cited by 6
Related Papers
Impact of concurrent antibody–drug conjugates and radiotherapy on symptomatic radiation necrosis in breast cancer patients with brain metastases: a multicenter retrospective study
|Journal of Neuro-Oncology|2024|34
Role of high-dose salvage radiotherapy for oligometastases of the localised abdominal/pelvic lymph nodes: a retrospective study
|BMC Cancer|2020|27
Risk of second primary malignancies after definitive treatment for esophageal cancer: A competing risk analysis
|Cancer Medicine|2019|23
A predictive model for pain response following radiotherapy for treatment of spinal metastases
|Scientific Reports|2021|23